Fig. 5: Microbiome mediated CLCuD suppression under SA producing strains Application.

a Salicylic Acid producing strains isolated from CLCuD resistant variety FDH-228. b Gossypium hirsutum PFV-1 control plant with no application (nA) exhibiting CLCuD symptoms at 20 DPI. c Gossypium hirsutum PFV-1 plant with application of strain R1 (uncultured Serratia spp.) resisting disease at 20 DPI. d CLCuD disease progression in Susceptible variety (PFV-2) under different applications: PFV2.R1 (uncultured Serratia spp.), PFV2.R2 (Bacillus spp.), PFV2.R3 (Fictibacillus spp.), PFV2.SC (Synthetic consortium of R1, R2, R3), PFV2.SA (Salicylic acid 400 mg/L positive control), PFV2.NA (No application- control) Statistically significant levels (Tukey’s HSD post hoc test) are indicated by asterisks as *p < 0.05, **p < 0.01, or ***p < 0.001. e CLCuD disease progression in Partially tolerant variety (PFV-1) under different applications: PFV1.R1 (uncultured Serratia spp.), PFV1.R2 (Bacillus spp.), PFV1.R3 (Fictibacillus spp.), PFV1.SC (Synthetic consortium of R1, R2, R3), PFV1.SA (Salicylic acid 400 mg/L positive control), PFV1.NA (No application- control). f, g are similar to d and e except that we have represented the results in disease severity index. Statistically significant levels (Tukey’s HSD post hoc test) are indicated by asterisks as *p < 0.05, **p < 0.01 or ***p < 0.001.